InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,894.84
(
1.94%
)
US TECH 100
20,123.20
(
2.21%
)
Dow Jones
43,560.53
(
3.17%
)
Brent Oil
75.53
(
0.18%
)
Bitcoin
74,250.00
(
7.12%
)
Post# of 473306
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Steady_T

Send PM Follow Ignore
Followers 167
Posts 20394
Boards Moderated 3
Alias Born 12/09/2004

Steady_T

Member Level

Re: mrplmer post# 442804

Friday, 12/15/2023 5:57:45 PM

Friday, December 15, 2023 5:57:45 PM

Post# of 473306
The FDA was the one dictating the adult trial. I do not think Anavex had a choice in the matter.
Independent... Well, they are separate trials with different trial population selections criteria.
They are the same drug treating the same disease, just in different age groups.

The FDA treats drugs for children with different standards for safety than it does for adults. Children are treated differently because they are still developing and growing so they have more opportunities for things to go wrong.

"Wise men talk because they have something to say, fools because they have to say something."
PLATO

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM

Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM

North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM

Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM

CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM

Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM

Start posting your company's news
Only $200 per official company press release!